Adequately 0 10 0 10 O
treated 11 18 11 18 O
non 19 22 19 22 B-cancer
- 22 23 22 23 I-cancer
melanoma 23 31 23 31 I-cancer
skin 32 36 32 36 I-cancer
cancer 37 43 37 43 I-cancer
or 44 46 44 46 O
lentigo 47 54 47 54 B-cancer
maligna 55 62 55 62 I-cancer
without 63 70 63 70 O
evidence 71 79 71 79 O
of 80 82 80 82 O
disease 83 90 83 90 O

Anticancer 0 10 91 101 B-treatment
therapy 11 18 102 109 I-treatment
including 19 28 110 119 O
chemotherapy 29 41 120 132 B-treatment
, 41 42 132 133 O
immunotherapy 43 56 134 147 B-treatment
, 56 57 147 148 O
radiotherapy 58 70 149 161 B-treatment
, 70 71 161 162 O
hormonal 72 80 163 171 B-treatment
or 81 83 172 174 I-treatment
any 84 87 175 178 I-treatment
investigational 88 103 179 194 I-treatment
therapy 104 111 195 202 I-treatment
within 112 118 203 209 O
14 119 121 210 212 B-upper_bound
days 122 126 213 217 I-upper_bound
or 127 129 218 220 O
5 130 131 221 222 O
half 132 136 223 227 O
- 136 137 227 228 O
lives 137 142 228 233 O
prior 143 148 234 239 O
to 149 151 240 242 O
first 152 157 243 248 O
dose 158 162 249 253 O
of 163 165 254 256 O
study 166 171 257 262 O
drug 172 176 263 267 O

Any 0 3 268 271 O
life 4 8 272 276 B-chronic_disease
- 8 9 276 277 I-chronic_disease
threatening 9 20 277 288 I-chronic_disease
illness 21 28 289 296 I-chronic_disease
, 28 29 296 297 O
medical 30 37 298 305 B-chronic_disease
condition 38 47 306 315 I-chronic_disease
, 47 48 315 316 O
or 49 51 317 319 O
organ 52 57 320 325 B-chronic_disease
system 58 64 326 332 I-chronic_disease
dysfunction 65 76 333 344 I-chronic_disease
that 77 81 345 349 O
, 81 82 349 350 O
in 83 85 351 353 O
the 86 89 354 357 O
investigator 90 102 358 370 O
's 102 104 370 372 O
opinion 105 112 373 380 O
, 112 113 380 381 O
could 114 119 382 387 O
compromise 120 130 388 398 O
the 131 134 399 402 O
subject 135 142 403 410 O
's 142 144 410 412 O
safety 145 151 413 419 O
or 152 154 420 422 O
put 155 158 423 426 O
the 159 162 427 430 O
study 163 168 431 436 O
outcomes 169 177 437 445 O
at 178 180 446 448 O
undue 181 186 449 454 O
risk 187 191 455 459 O

Bilirubin 0 9 460 469 B-clinical_variable
= 10 11 470 471 O
< 11 12 471 472 O
1.5 13 16 473 476 B-upper_bound
x 17 18 477 478 I-upper_bound
ULN 19 22 479 482 I-upper_bound
( 23 24 483 484 O
unless 24 30 484 490 O
bilirubin 31 40 491 500 O
rise 41 45 501 505 O
is 46 48 506 508 O
due 49 52 509 512 O
to 53 55 513 515 O
Gilbert 56 63 516 523 B-chronic_disease
's 63 65 523 525 I-chronic_disease
syndrome 66 74 526 534 I-chronic_disease
or 75 77 535 537 O
of 78 80 538 540 O
non 81 84 541 544 O
- 84 85 544 545 O
hepatic 85 92 545 552 O
origin 93 99 553 559 O
) 99 100 559 560 O

Concomitant 0 11 561 572 O
use 12 15 573 576 O
of 16 18 577 579 O
warfarin 19 27 580 588 B-treatment
or 28 30 589 591 O
other 31 36 592 597 O
vitamin 37 44 598 605 B-treatment
K 45 46 606 607 I-treatment
antagonists 47 58 608 619 I-treatment

Concurrent 0 10 620 630 O
systemic 11 19 631 639 B-treatment
immunosuppressant 20 37 640 657 I-treatment
therapy 38 45 658 665 I-treatment

Currently 0 9 666 675 O
active 10 16 676 682 O
, 16 17 682 683 O
clinically 18 28 684 694 O
significant 29 40 695 706 O
cardiovascular 41 55 707 721 B-chronic_disease
disease 56 63 722 729 I-chronic_disease
, 63 64 729 730 O
such 65 69 731 735 O
as 70 72 736 738 O
uncontrolled 73 85 739 751 O
arrhythmia 86 96 752 762 B-chronic_disease
or 97 99 763 765 O
class 100 105 766 771 O
3 106 107 772 773 O
or 108 110 774 776 O
4 111 112 777 778 O
congestive 113 123 779 789 B-chronic_disease
heart 124 129 790 795 I-chronic_disease
failure 130 137 796 803 I-chronic_disease
as 138 140 804 806 O
defined 141 148 807 814 O
by 149 151 815 817 O
the 152 155 818 821 O
New 156 159 822 825 B-clinical_variable
York 160 164 826 830 I-clinical_variable
Heart 165 170 831 836 I-clinical_variable
Association 171 182 837 848 I-clinical_variable
Functional 183 193 849 859 O
Classification 194 208 860 874 O
; 208 209 874 875 O
or 210 212 876 878 O
a 213 214 879 880 O
history 215 222 881 888 O
of 223 225 889 891 O
myocardial 226 236 892 902 B-chronic_disease
infarction 237 247 903 913 I-chronic_disease
, 247 248 913 914 O
unstable 249 257 915 923 B-chronic_disease
angina 258 264 924 930 I-chronic_disease
, 264 265 930 931 O
or 266 268 932 934 O
acute 269 274 935 940 B-chronic_disease
coronary 275 283 941 949 I-chronic_disease
syndrome 284 292 950 958 I-chronic_disease
within 293 299 959 965 O
6 300 301 966 967 B-upper_bound
months 302 308 968 974 I-upper_bound
prior 309 314 975 980 I-upper_bound
to 315 317 981 983 O
enrollment 318 328 984 994 O

Estimated 0 9 995 1004 B-clinical_variable
creatinine 10 20 1005 1015 I-clinical_variable
clearance 21 30 1016 1025 I-clinical_variable
> 31 32 1026 1027 O
= 32 33 1027 1028 O
30 34 36 1029 1031 B-lower_bound
ml 37 39 1032 1034 I-lower_bound
/ 39 40 1034 1035 I-lower_bound
min 40 43 1035 1038 I-lower_bound
( 44 45 1039 1040 O
Cockcroft 45 54 1040 1049 O
- 54 55 1049 1050 O
Gault 55 60 1050 1055 O
) 60 61 1055 1056 O

Female 0 6 1057 1063 B-gender
subjects 7 15 1064 1072 I-gender
who 16 19 1073 1076 O
are 20 23 1077 1080 O
of 24 26 1081 1083 O
non 27 30 1084 1087 O
- 30 31 1087 1088 O
reproductive 31 43 1088 1100 O
potential 44 53 1101 1110 O
( 54 55 1111 1112 O
ie 55 57 1112 1114 O
, 57 58 1114 1115 O
post 59 63 1116 1120 O
- 63 64 1120 1121 O
menopausal 64 74 1121 1131 O
by 75 77 1132 1134 O
history 78 85 1135 1142 O
- 86 87 1143 1144 O
no 88 90 1145 1147 O
menses 91 97 1148 1154 O
for 98 101 1155 1158 O
> 102 103 1159 1160 O
= 103 104 1160 1161 O
1 105 106 1162 1163 B-lower_bound
year 107 111 1164 1168 I-lower_bound
; 111 112 1168 1169 O
OR 113 115 1170 1172 O
history 116 123 1173 1180 O
of 124 126 1181 1183 O
hysterectomy 127 139 1184 1196 B-contraception_consent
; 139 140 1196 1197 O
OR 141 143 1198 1200 O
history 144 151 1201 1208 O
of 152 154 1209 1211 O
bilateral 155 164 1212 1221 B-contraception_consent
tubal 165 170 1222 1227 I-contraception_consent
ligation 171 179 1228 1236 I-contraception_consent
; 179 180 1236 1237 O
OR 181 183 1238 1240 O
history 184 191 1241 1248 O
of 192 194 1249 1251 O
bilateral 195 204 1252 1261 B-contraception_consent
oophorectomy 205 217 1262 1274 I-contraception_consent
) 217 218 1274 1275 O
; 218 219 1275 1276 O
or 220 222 1277 1279 O
, 222 223 1279 1280 O
female 224 230 1281 1287 B-gender
subjects 231 239 1288 1296 I-gender
of 240 242 1297 1299 O
childbearing 243 255 1300 1312 O
potential 256 265 1313 1322 O
must 266 270 1323 1327 O
have 271 275 1328 1332 O
a 276 277 1333 1334 O
negative 278 286 1335 1343 B-pregnancy
serum 287 292 1344 1349 I-pregnancy
pregnancy 293 302 1350 1359 I-pregnancy
test 303 307 1360 1364 O
upon 308 312 1365 1369 O
study 313 318 1370 1375 O
entry 319 324 1376 1381 O

For 0 3 1382 1385 O
the 4 7 1386 1389 O
dose 8 12 1390 1394 O
escalation 13 23 1395 1405 O
cohorts 24 31 1406 1413 O
, 31 32 1413 1414 O
any 33 36 1415 1418 O
prior 37 42 1419 1424 B-treatment
number 43 49 1425 1431 I-treatment
of 50 52 1432 1434 I-treatment
MDS 53 56 1435 1438 I-treatment
therapies 57 66 1439 1448 I-treatment
, 66 67 1448 1449 O
including 68 77 1450 1459 O
hypomethylating 78 93 1460 1475 B-treatment
agents 94 100 1476 1482 I-treatment

History 0 7 1483 1490 O
of 8 10 1491 1493 O
other 11 16 1494 1499 O
malignancies 17 29 1500 1512 B-cancer

History 0 7 1513 1520 O
of 8 10 1521 1523 O
stroke 11 17 1524 1530 B-chronic_disease
or 18 20 1531 1533 O
intracranial 21 33 1534 1546 B-chronic_disease
hemorrhage 34 44 1547 1557 I-chronic_disease
within 45 51 1558 1564 O
6 52 53 1565 1566 B-upper_bound
months 54 60 1567 1573 I-upper_bound
prior 61 66 1574 1579 I-upper_bound
to 67 69 1580 1582 O
enrollment 70 80 1583 1593 O

Karnofsky 0 9 1594 1603 B-clinical_variable
performance 10 21 1604 1615 I-clinical_variable
status 22 28 1616 1622 I-clinical_variable
( 29 30 1623 1624 I-clinical_variable
KPS 30 33 1624 1627 I-clinical_variable
) 33 34 1627 1628 I-clinical_variable
performance 35 46 1629 1640 I-clinical_variable
status 47 53 1641 1647 I-clinical_variable
of 54 56 1648 1650 O
60 57 59 1651 1653 B-lower_bound
% 59 60 1653 1654 I-lower_bound
or 61 63 1655 1657 O
greater 64 71 1658 1665 O

Known 0 5 1666 1671 O
bleeding 6 14 1672 1680 B-chronic_disease
disorders 15 24 1681 1690 I-chronic_disease
, 24 25 1690 1691 O
active 26 32 1692 1698 O
bleeding 33 41 1699 1707 O
disorders 42 51 1708 1717 O
or 52 54 1718 1720 O
clinical 55 63 1721 1729 O
signs 64 69 1730 1735 O
of 70 72 1736 1738 O
bleeding 73 81 1739 1747 O
( 82 83 1748 1749 O
grade 83 88 1749 1754 B-clinical_variable
> 89 90 1755 1756 O
= 90 91 1756 1757 O
2 92 93 1758 1759 B-lower_bound
) 93 94 1759 1760 O

Known 0 5 1761 1766 O
history 6 13 1767 1774 O
of 14 16 1775 1777 O
human 17 22 1778 1783 B-chronic_disease
immunodeficiency 23 39 1784 1800 I-chronic_disease
virus 40 45 1801 1806 I-chronic_disease
( 46 47 1807 1808 I-chronic_disease
HIV 47 50 1808 1811 I-chronic_disease
) 50 51 1811 1812 I-chronic_disease
or 52 54 1813 1815 O
active 55 61 1816 1822 O
with 62 66 1823 1827 O
hepatitis 67 76 1828 1837 B-chronic_disease
C 77 78 1838 1839 I-chronic_disease
virus 79 84 1840 1845 I-chronic_disease
( 85 86 1846 1847 I-chronic_disease
HCV 86 89 1847 1850 I-chronic_disease
) 89 90 1850 1851 I-chronic_disease
or 91 93 1852 1854 O
hepatitis 94 103 1855 1864 B-chronic_disease
B 104 105 1865 1866 I-chronic_disease
virus 106 111 1867 1872 I-chronic_disease
( 112 113 1873 1874 I-chronic_disease
HBV 113 116 1874 1877 I-chronic_disease
) 116 117 1877 1878 I-chronic_disease

Low 0 3 1879 1882 O
- 3 4 1882 1883 O
risk 4 8 1883 1887 O
prostate 9 17 1888 1896 B-cancer
cancer 18 24 1897 1903 I-cancer
after 25 30 1904 1909 B-treatment
curative 31 39 1910 1918 I-treatment
surgery 40 47 1919 1926 I-treatment

Major 0 5 1927 1932 B-treatment
surgery 6 13 1933 1940 I-treatment
within 14 20 1941 1947 O
4 21 22 1948 1949 B-upper_bound
weeks 23 28 1950 1955 I-upper_bound
of 29 31 1956 1958 O
first 32 37 1959 1964 O
dose 38 42 1965 1969 O
of 43 45 1970 1972 O
study 46 51 1973 1978 B-treatment
drug 52 56 1979 1983 I-treatment

Male 0 4 1984 1988 B-gender

Malignancy 0 10 1989 1999 B-cancer
treated 11 18 2000 2007 O
with 19 23 2008 2012 O
curative 24 32 2013 2021 B-treatment
intent 33 39 2022 2028 I-treatment
and 40 43 2029 2032 O
with 44 48 2033 2037 O
no 49 51 2038 2040 O
known 52 57 2041 2046 O
active 58 64 2047 2053 O
disease 65 72 2054 2061 O
present 73 80 2062 2069 O
for 81 84 2070 2073 O
> 85 86 2074 2075 O
= 86 87 2075 2076 O
1 88 89 2077 2078 B-lower_bound
years 90 95 2079 2084 I-lower_bound
before 96 102 2085 2091 I-lower_bound
the 103 106 2092 2095 O
first 107 112 2096 2101 O
dose 113 117 2102 2106 O
of 118 120 2107 2109 O
study 121 126 2110 2115 B-treatment
drug 127 131 2116 2120 I-treatment
and 132 135 2121 2124 O
felt 136 140 2125 2129 O
to 141 143 2130 2132 O
be 144 146 2133 2135 O
at 147 149 2136 2138 O
low 150 153 2139 2142 O
risk 154 158 2143 2147 O
for 159 162 2148 2151 O
recurrence 163 173 2152 2162 O
by 174 176 2163 2165 O
treating 177 185 2166 2174 O
physician 186 195 2175 2184 O

Pathologically 0 14 2185 2199 O
confirmed 15 24 2200 2209 O
diagnosis 25 34 2210 2219 O
of 35 37 2220 2222 O
myelodysplastic 38 53 2223 2238 B-cancer
syndrome 54 62 2239 2247 I-cancer

Prior 0 5 2248 2253 B-treatment
bone 6 10 2254 2258 I-treatment
marrow 11 17 2259 2265 I-treatment
transplant 18 28 2266 2276 I-treatment
within 29 35 2277 2283 O
3 36 37 2284 2285 B-upper_bound
months 38 44 2286 2292 I-upper_bound
or 45 47 2293 2295 O
with 48 52 2296 2300 O
acute 53 58 2301 2306 B-chronic_disease
graft 59 64 2307 2312 I-chronic_disease
versus 65 71 2313 2319 I-chronic_disease
host 72 76 2320 2324 I-chronic_disease
disease 77 84 2325 2332 I-chronic_disease
( 85 86 2333 2334 I-chronic_disease
GVHD 86 90 2334 2338 I-chronic_disease
) 90 91 2338 2339 I-chronic_disease

Prior 0 5 2340 2345 B-treatment
treatment 6 15 2346 2355 I-treatment
with 16 20 2356 2360 I-treatment
a 21 22 2361 2362 I-treatment
Bruton 23 29 2363 2369 I-treatment
's 29 31 2369 2371 I-treatment
tyrosine 32 40 2372 2380 I-treatment
kinase 41 47 2381 2387 I-treatment
( 48 49 2388 2389 I-treatment
BTK 49 52 2389 2392 I-treatment
) 52 53 2392 2393 I-treatment
inhibitor 54 63 2394 2403 I-treatment

Prothrombin 0 11 2404 2415 B-clinical_variable
time 12 16 2416 2420 I-clinical_variable
( 17 18 2421 2422 I-clinical_variable
PT)/international 18 35 2422 2439 I-clinical_variable
normalized 36 46 2440 2450 I-clinical_variable
ratio 47 52 2451 2456 I-clinical_variable
( 53 54 2457 2458 I-clinical_variable
INR 54 57 2458 2461 I-clinical_variable
) 57 58 2461 2462 I-clinical_variable
< 59 60 2463 2464 O
1.5 61 64 2465 2468 B-upper_bound
x 65 66 2469 2470 I-upper_bound
ULN 67 70 2471 2474 I-upper_bound
and 71 74 2475 2478 O
partial 75 82 2479 2486 B-clinical_variable
thromboplastin 83 97 2487 2501 I-clinical_variable
time 98 102 2502 2506 I-clinical_variable
( 103 104 2507 2508 I-clinical_variable
PTT 104 107 2508 2511 I-clinical_variable
) 107 108 2511 2512 I-clinical_variable
( 109 110 2513 2514 O
activated 110 119 2514 2523 B-clinical_variable
[ 120 121 2524 2525 I-clinical_variable
a]PTT 121 126 2525 2530 I-clinical_variable
) 126 127 2530 2531 O
< 128 129 2532 2533 O
1.5 130 133 2534 2537 O
x 134 135 2538 2539 O
ULN 136 139 2540 2543 O

Recent 0 6 2544 2550 O
infection 7 16 2551 2560 B-chronic_disease
requiring 17 26 2561 2570 O
intravenous 27 38 2571 2582 B-treatment
systemic 39 47 2583 2591 I-treatment
treatment 48 57 2592 2601 I-treatment

Requires 0 8 2602 2610 O
treatment 9 18 2611 2620 B-treatment
with 19 23 2621 2625 I-treatment
a 24 25 2626 2627 I-treatment
strong 26 32 2628 2634 I-treatment
cytochrome 33 43 2635 2645 I-treatment
P450 44 48 2646 2650 I-treatment
( 49 50 2651 2652 I-treatment
CYP 50 53 2652 2655 I-treatment
) 53 54 2655 2656 I-treatment
family 55 61 2657 2663 I-treatment
3 62 63 2664 2665 I-treatment
, 63 64 2665 2666 O
subfamily 65 74 2667 2676 B-treatment
A 75 76 2677 2678 I-treatment
, 76 77 2678 2679 O
polypeptide 78 89 2680 2691 B-treatment
4/5 90 93 2692 2695 I-treatment
( 94 95 2696 2697 I-treatment
3A4/5 95 100 2697 2702 I-treatment
) 100 101 2702 2703 I-treatment
inhibitor 102 111 2704 2713 I-treatment

Revised 0 7 2714 2721 B-clinical_variable
international 8 21 2722 2735 I-clinical_variable
prognostic 22 32 2736 2746 I-clinical_variable
scoring 33 40 2747 2754 I-clinical_variable
system 41 47 2755 2761 I-clinical_variable
( 48 49 2762 2763 I-clinical_variable
IPSS 49 53 2763 2767 I-clinical_variable
- 53 54 2767 2768 I-clinical_variable
R 54 55 2768 2769 I-clinical_variable
) 55 56 2769 2770 I-clinical_variable
intermediate 57 69 2771 2783 O
, 69 70 2783 2784 O
high 71 75 2785 2789 O
or 76 78 2790 2792 O
very 79 83 2793 2797 O
high 84 88 2798 2802 O

Serum 0 5 2803 2808 B-clinical_variable
aspartate 6 15 2809 2818 I-clinical_variable
transaminase 16 28 2819 2831 I-clinical_variable
( 29 30 2832 2833 I-clinical_variable
AST 30 33 2833 2836 I-clinical_variable
) 33 34 2836 2837 I-clinical_variable
and 35 38 2838 2841 I-clinical_variable
alanine 39 46 2842 2849 I-clinical_variable
transaminase 47 59 2850 2862 I-clinical_variable
( 60 61 2863 2864 I-clinical_variable
ALT 61 64 2864 2867 I-clinical_variable
) 64 65 2867 2868 I-clinical_variable
= 66 67 2869 2870 O
< 67 68 2870 2871 O
3.0 69 72 2872 2875 B-upper_bound
x 73 74 2876 2877 I-upper_bound
upper 75 80 2878 2883 I-upper_bound
limit 81 86 2884 2889 I-upper_bound
of 87 89 2890 2892 I-upper_bound
normal 90 96 2893 2899 I-upper_bound
( 97 98 2900 2901 I-upper_bound
ULN 98 101 2901 2904 I-upper_bound
) 101 102 2904 2905 I-upper_bound

Unable 0 6 2906 2912 O
to 7 9 2913 2915 O
swallow 10 17 2916 2923 O
capsules 18 26 2924 2932 O
or 27 29 2933 2935 O
malabsorption 30 43 2936 2949 B-chronic_disease
syndrome 44 52 2950 2958 I-chronic_disease
, 52 53 2958 2959 O
disease 54 61 2960 2967 O
significantly 62 75 2968 2981 O
affecting 76 85 2982 2991 O
gastrointestinal 86 102 2992 3008 O
function 103 111 3009 3017 O
, 111 112 3017 3018 O
or 113 115 3019 3021 O
resection 116 125 3022 3031 O
of 126 128 3032 3034 O
the 129 132 3035 3038 O
stomach 133 140 3039 3046 O
or 141 143 3047 3049 O
small 144 149 3050 3055 O
bowel 150 155 3056 3061 O
, 155 156 3061 3062 O
symptomatic 157 168 3063 3074 O
inflammatory 169 181 3075 3087 B-chronic_disease
bowel 182 187 3088 3093 I-chronic_disease
disease 188 195 3094 3101 I-chronic_disease
or 196 198 3102 3104 O
ulcerative 199 209 3105 3115 B-chronic_disease
colitis 210 217 3116 3123 I-chronic_disease
, 217 218 3123 3124 O
or 219 221 3125 3127 O
partial 222 229 3128 3135 O
or 230 232 3136 3138 O
complete 233 241 3139 3147 O
bowel 242 247 3148 3153 B-chronic_disease
obstruction 248 259 3154 3165 I-chronic_disease

Unresolved 0 10 3166 3176 O
toxicities 11 21 3177 3187 O
from 22 26 3188 3192 O
prior 27 32 3193 3198 B-treatment
anti 33 37 3199 3203 I-treatment
- 37 38 3203 3204 I-treatment
cancer 38 44 3204 3210 I-treatment
therapy 45 52 3211 3218 I-treatment
, 52 53 3218 3219 O
defined 54 61 3220 3227 O
as 62 64 3228 3230 O
having 65 71 3231 3237 O
not 72 75 3238 3241 O
resolved 76 84 3242 3250 O
to 85 87 3251 3253 O
Common 88 94 3254 3260 B-clinical_variable
Terminology 95 106 3261 3272 I-clinical_variable
Criteria 107 115 3273 3281 I-clinical_variable
for 116 119 3282 3285 I-clinical_variable
Adverse 120 127 3286 3293 I-clinical_variable
Event 128 133 3294 3299 I-clinical_variable
( 134 135 3300 3301 I-clinical_variable
CTCAE 135 140 3301 3306 I-clinical_variable
, 140 141 3306 3307 I-clinical_variable
version 142 149 3308 3315 I-clinical_variable
4.03 150 154 3316 3320 I-clinical_variable
) 154 155 3320 3321 I-clinical_variable
, 155 156 3321 3322 I-clinical_variable
grade 157 162 3323 3328 I-clinical_variable
= 163 164 3329 3330 O
< 164 165 3330 3331 O
1 166 167 3332 3333 B-upper_bound
, 167 168 3333 3334 O
or 169 171 3335 3337 O
to 172 174 3338 3340 O
the 175 178 3341 3344 O
levels 179 185 3345 3351 O
dictated 186 194 3352 3360 O
in 195 197 3361 3363 O
the 198 201 3364 3367 O
inclusion 202 211 3368 3377 O
/ 211 212 3377 3378 O
exclusion 212 221 3378 3387 O
criteria 222 230 3388 3396 O

Vaccinated 0 10 3397 3407 O
with 11 15 3408 3412 O
live 16 20 3413 3417 B-treatment
, 20 21 3417 3418 O
attenuated 22 32 3419 3429 B-treatment
vaccines 33 41 3430 3438 I-treatment
within 42 48 3439 3445 O
4 49 50 3446 3447 B-upper_bound
weeks 51 56 3448 3453 I-upper_bound
of 57 59 3454 3456 O
first 60 65 3457 3462 O
dose 66 70 3463 3467 O
of 71 73 3468 3470 O
study 74 79 3471 3476 B-treatment
drug 80 84 3477 3481 I-treatment

female 0 6 3482 3488 B-gender
subjects 7 15 3489 3497 I-gender

for 0 3 3498 3501 O
the 4 7 3502 3505 O
dose 8 12 3506 3510 O
expansion 13 22 3511 3520 O
cohort 23 29 3521 3527 O
, 29 30 3527 3528 O
subjects 31 39 3529 3537 O
must 40 44 3538 3542 O
be 45 47 3543 3545 O
azacitidine 48 59 3546 3557 B-treatment
naÃ¯ve 60 65 3558 3563 O
, 65 66 3563 3564 O
but 67 70 3565 3568 O
otherwise 71 80 3569 3578 O
any 81 84 3579 3582 O
prior 85 90 3583 3588 B-treatment
number 91 97 3589 3595 I-treatment
of 98 100 3596 3598 I-treatment
MDS 101 104 3599 3602 I-treatment
therapies 105 114 3603 3612 I-treatment

pregnant 0 8 3613 3621 B-pregnancy

transfusion 0 11 3622 3633 B-treatment
- 11 12 3633 3634 O
dependent 12 21 3634 3643 O
patients 22 30 3644 3652 O
are 31 34 3653 3656 O
eligible 35 43 3657 3665 O
and 44 47 3666 3669 O
platelet 48 56 3670 3678 B-clinical_variable
counts 57 63 3679 3685 I-clinical_variable
should 64 70 3686 3692 O
be 71 73 3693 3695 O
maintained 74 84 3696 3706 O
greater 85 92 3707 3714 O
than 93 97 3715 3719 O
10,000 98 104 3720 3726 B-lower_bound
/ 104 105 3726 3727 I-lower_bound
mm^3 105 109 3727 3731 I-lower_bound

who 0 3 3732 3735 O
agree 4 9 3736 3741 B-contraception_consent
to 10 12 3742 3744 I-contraception_consent
use 13 16 3745 3748 I-contraception_consent
highly 17 23 3749 3755 I-contraception_consent
effective 24 33 3756 3765 I-contraception_consent
methods 34 41 3766 3773 I-contraception_consent
of 42 44 3774 3776 I-contraception_consent
birth 45 50 3777 3782 I-contraception_consent
control 51 58 3783 3790 I-contraception_consent
during 59 65 3791 3797 O
the 66 69 3798 3801 O
period 70 76 3802 3808 O
of 77 79 3809 3811 O
therapy 80 87 3812 3819 B-treatment
and 88 91 3820 3823 O
for 92 95 3824 3827 O
30 96 98 3828 3830 B-upper_bound
days 99 103 3831 3835 I-upper_bound
after 104 109 3836 3841 I-upper_bound
the 110 113 3842 3845 O
last 114 118 3846 3850 O
dose 119 123 3851 3855 O
of 124 126 3856 3858 O
study 127 132 3859 3864 B-treatment
drug 133 137 3865 3869 I-treatment

